Drug intelligence / Profile preview

NGF6-B

Development stage: Preclinical
Lead developer: Alcon
Administration: Ophthalmic

Overview

NGF6-B is a test formulation developed by Alcon Research as an artificial tear product and ocular lubricant. It is being evaluated for its safety and tolerability when instilled as one drop on the eye.

Beyond the preview

Go deeper on NGF6-B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NGF6-B.

Explore the full profile